Serial Number | 79305516 |
Word Mark | HEMESIGHT |
Filing Date | Tuesday, December 15, 2020 |
Status | 700 - REGISTERED |
Status Date | Tuesday, May 24, 2022 |
Registration Number | 6733728 |
Registration Date | Tuesday, May 24, 2022 |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, March 8, 2022 |
Goods and Services | Diagnostic preparations for medical purposes for diagnosing and treating cancer through genetic testing; diagnostic reagents for medical use in diagnosing cancer |
Pseudo Mark | HEME SIGHT |
Goods and Services | Providing medical information in the field of genetic and sequencing testing for the diagnosis and treatment of cancer; medical diagnostic services in the nature of performing diagnosis of disease in the field of cancer diagnostics; medical testing for diagnostic or treatment purposes, namely, genetic testing and sequencing tests for diagnosis and treatment of cancer |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Friday, March 12, 2021 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Friday, March 12, 2021 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Otsuka Pharmaceutical Co., Ltd. |
Party Type | 30 - Original Registrant |
Legal Entity Type | 03 - Corporation |
Address | JP |
Party Name | Otsuka Pharmaceutical Co., Ltd. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | JP |
Party Name | Otsuka Pharmaceutical Co., Ltd. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | JP |
Event Date | Event Description |
Monday, March 13, 2023 | NEW REPRESENTATIVE AT IB RECEIVED |
Sunday, October 2, 2022 | FINAL DECISION TRANSACTION PROCESSED BY IB |
Thursday, September 8, 2022 | FINAL DISPOSITION NOTICE SENT TO IB |
Thursday, September 8, 2022 | FINAL DISPOSITION PROCESSED |
Wednesday, August 24, 2022 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
Tuesday, May 24, 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
Tuesday, May 24, 2022 | REGISTERED-PRINCIPAL REGISTER |
Tuesday, March 8, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, March 8, 2022 | PUBLISHED FOR OPPOSITION |
Monday, March 7, 2022 | NOTIFICATION PROCESSED BY IB |
Wednesday, February 16, 2022 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
Wednesday, February 16, 2022 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
Wednesday, February 16, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Friday, January 28, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Friday, January 28, 2022 | EXAMINER'S AMENDMENT ENTERED |
Friday, January 28, 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Friday, January 28, 2022 | EXAMINERS AMENDMENT E-MAILED |
Friday, January 28, 2022 | EXAMINERS AMENDMENT -WRITTEN |
Friday, December 17, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Thursday, December 16, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Thursday, December 16, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Monday, July 5, 2021 | REFUSAL PROCESSED BY IB |
Wednesday, June 16, 2021 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Wednesday, June 16, 2021 | REFUSAL PROCESSED BY MPU |
Friday, June 11, 2021 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Thursday, June 10, 2021 | NON-FINAL ACTION WRITTEN |
Wednesday, June 2, 2021 | ASSIGNED TO EXAMINER |
Tuesday, March 16, 2021 | APPLICATION FILING RECEIPT MAILED |
Friday, March 12, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Thursday, March 11, 2021 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
Thursday, March 4, 2021 | SN ASSIGNED FOR SECT 66A APPL FROM IB |